A carregar...
New Studies Reveal Potential Mechanisms of Resistance to CDK4/6 Inhibitors in HR+/HER2– Breast Cancer
Research focused on barriers to the real‐world use of CDK4/6 inhibitor therapy in patients with HR+/HER2– breast cancer reveals potential mechanisms and biomarkers of drug resistance.
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8262301/ https://ncbi.nlm.nih.gov/pubmed/34181796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13875 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|